Share

The Technology Behind Bluebird Bio

Share This:

May.19 — Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston’s biotech scene, and venture capital with Bloomberg’s Caroline Hyde on “Bloomberg Technology” at the Museum of Science in Boston on May 9.

Leave a Comment